Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

A Roper

Showing results (191-200 of 205) with videos related to

Pageof 21
Sort By:
Journal of Medicinal Chemistry|October 17, 2024
Core Modifications of GSK3335103 toward Orally Bioavailable α<sub>v</sub>β<sub>6</sub> Inhibitors with Improved Synthetic TractabilityHeather F Hryczanek, John Barrett, Tim N Barrett, et al.
Journal of Medicinal Chemistry|May 28, 2024
Discovery of the Selective and Orally Available Galectin-1 Inhibitor GB1908 as a Potential Treatment for Lung CancerFredrik R Zetterberg, Kristoffer Peterson, Ulf J Nilsson, et al.
Geroscience|December 17, 2025
Beyond strength: dietary nitrate augments self-selected functional mobility after resistance training in middle-aged adultsBrandon M Peoples, Mason C McIntosh, Kenneth D Harrison, et al.
Nature|July 6, 2018
Single-cell analysis of early progenitor cells that build coronary arteriesTianying Su, Geoff Stanley, Rahul Sinha, et al.
Journal of Medicinal Chemistry|August 6, 2019
Profile of a Highly Selective Quaternized Pyrrolidine Betaine α<sub>v</sub>β<sub>6</sub> Integrin Inhibitor-(3<i>S</i>)-3-(3-(3,5-Dimethyl-1<i>H</i>-pyrazol-1-yl)phenyl)-4-((1<i>S</i> and 1<i>R</i>,3<i>R</i>)-1-methyl-3-(2-(5,6,7,8-tetrahydro-1,8-naphthyridin-2-yl)ethyl)pyrrolidin-1-ium-1-yl)butanoate Synthesized by Stereoselective MethylationTim N Barrett, Jonathan A Taylor, Daniel Barker, et al.
Leukemia|July 17, 2025
Hypomethylating agents induce epigenetic and transcriptional heterogeneity with implications for acute myeloid leukemia cell self-renewalDanielle R Bond, Sean M Burnard, Kumar Uddipto, et al.
AJNR. American Journal of Neuroradiology|January 26, 2023
Connectomic Basis for Tremor Control in Stereotactic Radiosurgical ThalamotomyE H Middlebrooks, R A Popple, E Greco, et al.
Cell Reports. Medicine|July 19, 2023
A surgically optimized intraoperative poly(I:C)-releasing hydrogel prevents cancer recurrenceFrancois Xavier Rwandamuriye, Cameron W Evans, Ben Wylie, et al.
Journal of Neurosurgery|February 14, 2025
Connectomic-guided stereotactic radiosurgery thalamotomy for tremor: a patient-specific approach to enhance outcomesErik H Middlebrooks, Vishal Patel, Richard A Popple, et al.
European Journal of Pharmacology|November 11, 2021
Pharmacological characterisation of GSK3335103, an oral αvβ6 integrin small molecule RGD-mimetic inhibitor for the treatment of fibrotic diseaseAlex L Wilkinson, Alison E John, John W Barrett, et al.
Pageof 21

Showing results (191-200 of 205) with videos related to

Sort By:
Pageof 21
Journal of Medicinal Chemistry|October 17, 2024
Core Modifications of GSK3335103 toward Orally Bioavailable α<sub>v</sub>β<sub>6</sub> Inhibitors with Improved Synthetic TractabilityHeather F Hryczanek, John Barrett, Tim N Barrett, et al.
Journal of Medicinal Chemistry|May 28, 2024
Discovery of the Selective and Orally Available Galectin-1 Inhibitor GB1908 as a Potential Treatment for Lung CancerFredrik R Zetterberg, Kristoffer Peterson, Ulf J Nilsson, et al.
Geroscience|December 17, 2025
Beyond strength: dietary nitrate augments self-selected functional mobility after resistance training in middle-aged adultsBrandon M Peoples, Mason C McIntosh, Kenneth D Harrison, et al.
Nature|July 6, 2018
Single-cell analysis of early progenitor cells that build coronary arteriesTianying Su, Geoff Stanley, Rahul Sinha, et al.
Journal of Medicinal Chemistry|August 6, 2019
Profile of a Highly Selective Quaternized Pyrrolidine Betaine α<sub>v</sub>β<sub>6</sub> Integrin Inhibitor-(3<i>S</i>)-3-(3-(3,5-Dimethyl-1<i>H</i>-pyrazol-1-yl)phenyl)-4-((1<i>S</i> and 1<i>R</i>,3<i>R</i>)-1-methyl-3-(2-(5,6,7,8-tetrahydro-1,8-naphthyridin-2-yl)ethyl)pyrrolidin-1-ium-1-yl)butanoate Synthesized by Stereoselective MethylationTim N Barrett, Jonathan A Taylor, Daniel Barker, et al.
Leukemia|July 17, 2025
Hypomethylating agents induce epigenetic and transcriptional heterogeneity with implications for acute myeloid leukemia cell self-renewalDanielle R Bond, Sean M Burnard, Kumar Uddipto, et al.
AJNR. American Journal of Neuroradiology|January 26, 2023
Connectomic Basis for Tremor Control in Stereotactic Radiosurgical ThalamotomyE H Middlebrooks, R A Popple, E Greco, et al.
Cell Reports. Medicine|July 19, 2023
A surgically optimized intraoperative poly(I:C)-releasing hydrogel prevents cancer recurrenceFrancois Xavier Rwandamuriye, Cameron W Evans, Ben Wylie, et al.
Journal of Neurosurgery|February 14, 2025
Connectomic-guided stereotactic radiosurgery thalamotomy for tremor: a patient-specific approach to enhance outcomesErik H Middlebrooks, Vishal Patel, Richard A Popple, et al.
European Journal of Pharmacology|November 11, 2021
Pharmacological characterisation of GSK3335103, an oral αvβ6 integrin small molecule RGD-mimetic inhibitor for the treatment of fibrotic diseaseAlex L Wilkinson, Alison E John, John W Barrett, et al.
Pageof 21